The cornified cell envelope (CE) of terminally differentiating stratified squamous epithelial cells is a complex multiprotein assembly about 15 nm thick of which loricrin is a major component. We have produced transgenic mice bearing the human loricrin transgene in order to study the role of loricrin in CE assembly, structure, and function. By analyses of RNA and protein, we show that the human transgene is expressed in mouse epithelial tissues in an appropriate developmental manner but at an overall level about twice that of endogenous mouse loricrin. Thus the 20-kbp construct used contains all necessary regulatory elements. By immunogold electron microscopy, all of the expressed protein is incorporated into the CE. That no alternations were noted indicates that overproduction of the loricrin component of the CE does not affect the flexible structure or function of the epithelial tissues. Furthermore, these data imply that loricrin may be the last protein to be deposited onto, and thus lines, the intracellular surface of the CE, where it may be accessible to interact with the subjacent keratin intermediate-ifiament network.
ABSTRACT
The cornified cell envelope (CE) of terminally differentiating stratified squamous epithelial cells is a complex multiprotein assembly about 15 nm thick of which loricrin is a major component. We have produced transgenic mice bearing the human loricrin transgene in order to study the role of loricrin in CE assembly, structure, and function. By analyses of RNA and protein, we show that the human transgene is expressed in mouse epithelial tissues in an appropriate developmental manner but at an overall level about twice that of endogenous mouse loricrin. Thus the 20-kbp construct used contains all necessary regulatory elements. By immunogold electron microscopy, all of the expressed protein is incorporated into the CE. That no alternations were noted indicates that overproduction of the loricrin component of the CE does not affect the flexible structure or function of the epithelial tissues. Furthermore, these data imply that loricrin may be the last protein to be deposited onto, and thus lines, the intracellular surface of the CE, where it may be accessible to interact with the subjacent keratin intermediate-ifiament network.
The cornified cell envelope (CE) is a 15-nm-thick layer of protein deposited on the intracellular surface of the plasma membrane of terminally differentiating stratified squamous epithelia tissues, where its major role is to provide a barrier against the environment (1, 2). The highly insoluble nature of the CE can be attributed to crosslinking of its constituent proteins by both disulfide bonds and NE-(--glutamyl)lysine isodipeptide bonds formed by the action of transglutaminases. Likely CE proteins include involucrin (3, 4) , cystatin A (5, 6), members of the class of small proline-rich proteins (7) (8) (9) , trichohyalin (10), loricrin (11, 12) , and possibly other proteins such as filaggrin and keratin intermediate filaments (13, 14) . To date, only loricrin has been shown to be crosslinked directly to the CE by isodipeptide bonds (12) .
Thus, major questions arise as to the relative contributions of these proteins to the structure, organization, and function of the CE. It has proven difficult to ascertain the temporal order of expression, the abundance, and the function of these proteins in the CE because the irreversibly crosslinked nature of the CE precludes dissection of the structure and because several of the proteins appear to be expressed concurrently very late in terminal differentiation in epithelia such as the epidermis (1, 2) . However, some structure-function data are now emerging. Due to their elongated a-helical structures, involucrin (15) and trichohyalin (10) have been suggested to serve as "scaffold" proteins in the CE, to which other more abundant proteins are later attached. Also, two types of data suggest that loricrin is the major CE component: its mRNA represents about 10% of the total in such tissues as the epidermis (10) (11) (12) (13) , and its amino acid composition is strikingly similar to that of isolated epidermal CEs, especially with respect to the high content of glycine and serine (11) (12) (13) . These glycine/serine-rich sequences are thought to adopt a The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
novel glycine loop motif which is variable in sequence and highly flexible in likely conformation (16, 17) . Since the same glycine loop motifexists on the keratin intermediate filaments also expressed in terminally differentiated epithelial cells (16, (18) (19) (20) , it was proposed that an interaction between the glycine loop sequences of loricrin on the CE and on the intracellular keratin intermediate filaments may stabilize cellular structure (16) .
Attempts to test these hypotheses and to study the structure and function of loricrin have proven difficult for several reasons. First, loricrin is poorly expressed in established epithelial cell culture systems (21) . In our hands, transfections of loricrin constructs into a wide variety of cells have resulted in very little or no expression, apparently because it is toxic (unpublished observations). Further, it has not been possible to isolate loricrin for direct biochemical experiments apparently because it is rapidly crosslinked after synthesis (11) . As an alternative, we have explored the expression of the human loricrin gene in transgenic mice. A 20-kbp genomic construct was found to direct the net overexpression of human loricrin that is assimilated without evident pathology. We interpret this to mean that it is a very late component of CE assembly, so that the intracellular surface is layered with loricrin, an event that is consistent with the hypothesis for an interaction between loricrin and the keratin intermediate filaments.
MATERIALS AND METHODS
Construction of the Human Loricrin Transgene. A plasmid containing the human loricrin gene was constructed by standard methods in three steps. An existing human loricrin genomic clone which contained about 1.5 kbp of 5' and 9 kbp of 3' flanking sequences (17) was cleaved at its unique BssHII site in the coding sequence. By use of PCR the coding sequence 3' to this site was modified by insertion of a 27-bp fragment encoding the carboxyl-terminal part of the neuropeptide substance P sequence, just prior to the termination codon. The substance P nucleotide sequence (but not coding sequence) was modified by creation ofa unique Sal I site. The engineered fragment was then reinserted into the genomic clone. Next, a 9-kbp genomic clone harboring sequence 5' to the loricrin cap site was isolated by standard procedures (17) and ligated to the assembly. The final construct of about 20 kbp ( Fig. 1) was assembled in the pGEM-3Z vector (Promega) and contained in the following linear order, 5' to 3', about 9 kbp of 5' flanking sequence; the entire human loricrin gene consisting of exon I in 5' untranslated sequence, intron 1, and exon II modified with the substance P peptide; and about 8.6 kbp of 3' noncoding sequence. Unique Sph I and Xba I sites at the 5' and 3' ends ofthe construct were used to excise the DNA from the plasmid vector.
Transgenic Mice. The construct was microinjected into fertilized mouse eggs [(C57BL6/J x SJLJ)F1, The Jackson Laboratory] essentially as described (22 were identified by PCR using two synthetic oligonucleotides: plus strand in the substrance P tag, 5'-GTCGACTGTCAGT-TCTTCGG-3', and minus strand in 3' noncoding sequence, 5'-CACCTTTCCGCCAATAGAGT-3'. PCRs employed a commercial DNA amplification kit (Perkin-Elmer/Cetus) with an initial denaturation at 95°C (1.5 min) and 30 cycles of denaturation at 95°C (0.5 min), annealing at 54°C (1 min), and elongation at 72°C (1 min), with 1 ug of genomic DNA.
Miscellaneous Procedures. RNA was isolated from heatseparated epidermis or other tissues by extraction with guanidine hydrochloride (23) . Northern blots (12) were probed with either the substance P oligonucleotide defined above (for specific reaction of hL.P transcripts only) or a human loricrin cDNA coding probe (12) (which crossreacts with both the endogenous mouse and hL.P transcripts). RNA PCR experiments were done with DNase I-treated total cellular RNA (2 ng) of transgenic and nontransgenic animals (24) . The two primers listed above generate a product of 390 bp only for the human transgenic construct, as shown by electrophoresis in a 1% agarose gel (NuSieve, FMC). Two other primers-plus, 5'-TACCTGGCCGTGCAAGTAAG-3', and minus, 5'-ACACCTTGAGCGACTCAATG-3'-gave a product of 173 bp for the endogenous mouse loricrin only. Total epidermal RNA from several homozygous transgenic mice was pooled and used for in vitro translation with the New England Nuclear kit and [35S]-cysteine (11), followed by immunoprecipitation with either an anti-loricrin antibody elicited against the carboxyl-terminal end (11, 12) , which reacts with both mouse and human loricrins, or an antisubstance P antibody (Wako Biochemicals, Osaka) (11, 12) . We found that incorporation into translated loricrins was linear between 1 and 20 ,ug of total RNA; for quantitation purposes, 10 ,ug was used. Autoradiograms were scanned on a phospho-imaging device with IMAGEQUANT software version 3.0 (Molecular Dynamics). Immunofluorescence (12) and immuno-electron microscopy procedures using protein A-gold were done with these two antibodies as described (24) .
Epidermal Cell Culture. Epidermis from homozygous transgenic mice was harvested and cells were cultured in low-calcium (0.05 mM CaCl2) medium for 6 days (21). Some cultures were shifted to high-calcium (0.35 mM) at day 4 and cultured for 2 days, as described (21) . RNA was then extracted, probed by slot blotting as above, followed by quantitation by phosphoimaging.
Estimation of hL.P Expression by Amino Acid Analysis. CEs were isolated from newborn mouse epidermis and their amino acid compositions were determined (12) . Calculations of the relative abundances of loricrins based on their known amino acid compositions employed an established algorithm (13 levels of structural homology in terms of their glycine loop motifs, as well as sequence homology, especially in their amino-and carboxyl-terminal glutamine-rich sequences. Accordingly, we configured the substance P neuropeptide sequence just prior to the termination codon ( Fig. 1 ) in order to follow the expression of human loricrin (termed hL.P) in the mouse background at both the nucleic acid and protein levels. The 20-kbp construct used contained the entire human loricrin gene of 2 kbp flanked by about 9 kbp on each side (Fig.  1) . Following injection of this construct, three founder lines were produced, which by PCR analysis and Southern blot analysis using specific primers, had stably incorporated about five copies into the mouse genome (data not shown). Such founders were then bred to produce heterozygous F1 and homozygous F2 transgenic colonies. Mice of each of these lines were normal.
Correct Tissue Expression of hL.P mRNA. Northern blot analyses of epidermal RNA from transgenic mice revealed the presence of transcripts of both the endogenous mouse (1.6 kb) and human (1.3 kb) loricrins, but the hL.P transcript was not seen in nontransgenic littermates or wild-type mice (Fig. 2) . In a survey of tissues by RNA PCR (Fig. 3 ), hL.P mRNA was expressed only in the stratified squamous epithelia of epidermis, palate, stomach, tongue and esophagus (see Fig. 6 ) or vagina (data not shown), but not in various tissues such as brain, heart, kidney, liver, lung and muscle, exactly as reported for mouse loricrin (11 the mouse loricrin at day 16 (Fig. 4) , as expected for late epithelial differentiation products (25) .
High Levels ofhL.P mRNA. We used two methods to assess the relative amount of hL.P mRNA in tissues. In the first, Northern blots as in Fig. 2 were scanned in a phosphoimaging device. The relative hybridization efficiencies of the loricrin probe with the mouse loricrin and hL.P mRNAs were corrected by using standard loricrin probes in slot blotting experiments (10) . In this way, we found that hL.P mRNA was 1.7-1.8 times more abundant than endogenous mouse loricrin mRNA in epidermis, esophagus, and stomach of homozygous transgenic mice. In a second approach, epidermal RNA from a litter of homozygous transgenic mice, as well as from nontransgenic and wild-type mice, was separately pooled and translated in vitro in the presence of [35S]cysteine with a commercial cell-free system. After immunoprecipitation with either the anti-loricrin or the anti-substance P antibodies, the products were resolved by polyacrylamide gel electrophoresis and fluorography. Fig. 5 shows that the former antibody precipitated both 60-kDa (mouse loricrin) and 30-kDa hL.P products (lane 5), whereas the latter antibody precipitated only the hL.P (lane 6) . These data therefore confirm that full-length hL.P mRNA is indeed expressed. The same fluorograph was used to quantitate the bands of lanes 1 and 5. 3, and 5 ) or anti-substance P antibody (lanes 2, 4, 6) for SDS/7.5% PAGE. Bands were then quantitated in a phosphoimaging device to estimate the relative amounts of mouse and hL.P mRNA transcripts. RNA was from epidermis of wild-type mice (Wt m, lanes 1 and 2) or homozygous transgenic mice (TgTg, lanes 5 and 6) or from normal human foreskins (NH, lanes 3 and 4) . for normal loricrin expression (21) were also retained on the transgene. Total cellular RNA from epidermal keratinocytes grown in low (0.05 mM) or high [0.35 mM, known to be optimal for expression of human loricrin (21)] calcium from wild-type, nontransgenic littermates or homozygous transgenic animals was extracted, slot blotted, examined with the two loricrin probes, and quantitated by phosphoimaging. The level of hL.P or mouse loricrin mRNA expression (arbitrary units) in low calcium was bearly detectable (background) at 10 ± 8. Expression of hL.P in high calcium was background of 8 t 10 in nontransgenic or wild-type animals but was 125 ± 4 in transgenic animals. This 10-fold increase indicates that the calcium-responsive elements for correct hL.P expression are contained within the 20-kbp construct used.
High Levels of hL.P Protein Synthesis as Determined by Amino Acid Analysis. To date, it has not been possible to isolate intact loricrin from any epithelial tissue, to determine its abundance directly, apparently because it is crosslinked shortly after synthesis (11) , but indirect estimates have been possible by use of amino acid analyses (13) . Epidermal CEs from wild-type or nontransgenic mice contain 45.1% glycine (11) , from which it is possible to calculate by least-squares fitting methods that mouse loricrin (55.1% glycine) constitutes about 75% of the CE protein, and the several other proteins cumulatively amount to about 25% of the CE (13) . By amino acid analysis, we found that epidermal CEs isolated TI G from homozygous transgenic animals contained 46.8 ± 0.3% glycine, which corresponds to a substantial net increase in the total amount of loricrin. Since the RNA translation data of Fig. 5 show that amount of expressed mouse loricrin remains constant in transgenic animals, this increase in glycine is attributable to expression ofthe hL.P (47.1%). With the same algorithms, this corresponds to about 1.8 times more hL.P than endogenous mouse loricrin.
Overexpression of hL.P Does Not Produce an Abnormal
Phenotype. In view of these data that indicate substantial overexpression of the hL.P in the mouse background, we surveyed the entire body of newborn homozygous transgenic animals by both light (Fig. 6 ) and electron (Fig. 7) microscopy. We found no unusual morphology or evident pathology in any tissue, including the epidermis, where hL.P was expressed most abundantly (Fig. 6A) . Deposition of the endogenous mouse loricrin (Fig. 6B ) or hL.P (Fig. 6 C-G) in trunk epidermis (Fig. 6 C and D) , esophagus (Fig. 6E) , stomach (Fig. 6F) , or the two epidermal layers of both sides of the ear (Fig. 6G) probably due to background (24) . This means that virtually all of the expressed endogenous mouse and hL.P loricrins are ultimately incorporated into the CE, as supported by amino acid analysis. Whereas all mouse loricrin gold particles were localized to the loricrin granules of the epidermis (Fig. 7C ) (12, 24) , in the case of the hL.P antibody, about 20% of the gold particles were localized over the filaggrin granules (Fig.  7E) . Normal human epidermis does not contain defined loricrin granules, but the human loricrin is deposited into compound granules together with profilaggrin (17) . Thus the hL.P contains all of the features that enable it to be assimilated in the same way as for endogenous loricrin. Concluding Remarks: Is Loricrin the Last Component Added During CE Assembly? The present experiments have documented at both the mRNA and protein levels that a 20-kbp construct directs the correct temporal and sitespecific expression of the human loricrin transgene in transgenic mice, at a net level 1.6-1.8 times greater than for endogenous mouse loricrin. The nearly 3-fold increase in the total amount of loricrin creates no detectable abnormality in any tissue or in the life of the mouse. Thus, events involved in the orderly assembly of the CE have not been interferred with. In contrast, overexpression of involucrin in transgenic mice produces an abnormal phenotype in both the epidermis and hair follicles, presumably because it is an early scaffold protein essential for correct CE formation (26) . Although our new data do not directly address the question of temporal expression, according to in situ hybridization and immunological studies, loricrin is expressed later during epidermal differentiation than involucrin, cystatin A, and the small proline-rich proteins (6, 7, 17, 24) . Thus, one possible explanation of why overexpression of loricrin does not produce a negative phenotype is that loricrin may be deposited over the preexisting scaffold at a very late or the last step of CE assembly. Accordingly, these conclusions provide support for the hypothesis (16) that the intracellular surface of the CE consists mostly of loricrin and that its main function is to provide flexibility to the epidermis by interaction with the immediately subjacent network of keratin intermediate filaments in the terminally differentiated cells.
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